• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Gastrointestinal stromal tumor in severely anemic Jehovah’s witness patient: A case report and literature review

Gastrointestinal stromal tumor in severely anemic Jehovah’s witness patient: A case report and literature review

Paul R Clark, MD. Florida State University college of medicine

Introduction: The aim of this manuscript is to present a case of gastrointestinal stromal tumor in severely anemic Jahovah’s witness patient and to discuss management options. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the GI tract and represent ~ 0.1-3% of all GI tumors. A review of the current literature is also presented.

Case Presentation: The authors present the case of a 66-year-old female who is a practicing Jahovah’s witness presenting with headache and dark tarry stools. Patient was found to be severely anemic; Hb of 5.4. Endoscopy showed a prolapsed nodular lesion in the cardia roughly 2.5 cm with superficial ulceration and active bleeding, this was treated with epi injection and APC ablation. Patient was taken to the operating room and underwent a laparoscopic partial gastrectomy, hiatal hernia repair and intraoperative EGD. Blood loss was minimal and post op Hb was stable at 5.4. Pathology revealed clear margins with 5.7 cm greatest diameter, mitotic count 1 per 50 HPF. The tumor was therefore intermediate risk, requiring no adjuvant Imantinib therapy and surveillance with CT q 3-6 months for 1st 3-5 years providing a estimated recurrence free survival 2-5 yrs > 90 % and 10 yrs 80-87 %. Patient was discharged on erythropoietin post operative day 3.

Conslusion: Gastrointestinal stromal tumors (GISTs) rare neoplasms representing ~ 0.1-3% of all GI malignancies. GISTs are most commonly found in the stomach and present with bleeding. CT with IV contrast is recommended imaging modality and preoperative biopsy is not routinely necessary for a primary resectable neoplasm suspicious for GIST and may increase risk of rupture w/ dissemination or bleeding. However if metastatic disease suspected or differential includes other malignancies such as lymphoma a biopsy is warranted. In 2008 Imantinib (antineoplastic tyrosine kinase inhibitor) was approved for daily dose of 400mg by FDA for adjuvant therapy for high risk patients following complete resection and is recommended for adjuvant therapy depending on an estimation of the risk of recurrence, which is based on tumor size, mitotic index, location in GI tract, and the presence or absence of tumor rupture (either spontaneously or during surgery). Minimally invasive laparoscopic resection of primary GISTs can be preformed following basic oncologic principles and is particularly appealing in patients with bleeding with contraindications to transfusion.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 79577

Program Number: P602

Presentation Session: Poster (Non CME)

Presentation Type: Poster

44

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals